Endocrinology

A novel treatment called regulation of cues combined with behavioral weight loss (ROC+BWL) was more effective than standard cognitive behavioral therapy (CBT) in reducing binge eating among veterans with overweight or obesity even 6 months after treatment ended, particularly for veterans with binge eating disorder, according to recently published study data. Read More ›

Whether it be a recent move by the Department of Health and Human Services (HHS) to meet with industry leaders to change prior authorization processes for Medicare Advantage, Medicaid Managed Care, Health Insurance Marketplace and commercial plans, or a massive overhaul of the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), President Trump’s new administration’s presence has definitely made itself known in recent months. Read More ›

Injectable GLP-1 drugs like semaglutide and tirzepatide may produce smaller weight loss in a “real-world” setting because patients may be more prone to discontinue treatment or use lower maintenance dosages than was used in clinical trials, according to recently published study results. Read More ›

Continuous glucose monitor (CGM)-derived metrics are going to continue to guide clinical decisions on patients with diabetes, and may have the potential to be even more impactful on the future of type 2 diabetes patients than even advancements in medication, according to 2 separately presented pieces of data at the 85th Scientific Sessions of the American Diabetes Association held in Chicago recently. Read More ›

The FDA has approved a rapid-acting human insulin biosimilar to Novolog (Novo Nordisk), insulin-aspart-szjj (Merilog; Sanofi-Aventis), for glycemic control in adults and pediatric patients with diabetes mellitus. Read More ›